| Jennifer Boylan, LPC | |
|
8 Legeyt Rd, Barkhamsted, CT 06063-1128 | |
| (860) 985-4303 | |
| Not Available |
| Full Name | Jennifer Boylan |
|---|---|
| Gender | Female |
| Speciality | Counselor |
| Location | 8 Legeyt Rd, Barkhamsted, Connecticut |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1952015240 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101Y00000X | Counselor | 2699 (Connecticut) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer Boylan, LPC 8 Legeyt Rd, Barkhamsted, CT 06063-1128 Ph: (860) 985-4303 | Jennifer Boylan, LPC 8 Legeyt Rd, Barkhamsted, CT 06063-1128 Ph: (860) 985-4303 |
News Archive
Governments and international donors are falling short of their goals of providing antiretroviral drugs to HIV-positive people in developing countries who need them, according to a report released on Tuesday by the International Treatment Preparedness Coalition, the International Herald Tribune reports.
caprotec bioanalytics GmbH today announced the closing of a EUR 4 million ($5.1M) Series B Financing Round with existing investors Creathor Venture, IBB Beteiligungsgesellschaft, ERP Startfonds, and well-known private investors. The proceeds will enable further development and marketing of the Company's proprietary CCMS (Capture Compound Mass Spectrometry) platform technology for analyzing complex protein mixtures.
Fetal growth is used as a marker of health and well-being in unborn babies as well as children. But, the tools that are currently available to differentiate between a small, healthy fetus and a fetus that is small due to pathologic causes have significant limitations. What if they were improved. Would it save the health care system resources spent monitoring women who might need medical intervention because their fetuses might just be small and healthy. Would it help some women avoid the anxiety such intervention brings.
Dartmouth researchers explored the type and number of connections in transcription factor networks (TFNs) to evaluate the role assortativity plays on robustness in a study published in PLOS Computational Biology in August.
Cancer Research UK is extremely disappointed that the advanced prostate cancer drug, abiraterone, has been ruled too expensive for routine use by the Scottish Medicines Consortium (SMC).
› Verified 6 days ago
Miss Alyssa Rose Cumpstone, Counselor Medicare: Not Enrolled in Medicare Practice Location: 86 Bsullak Rd, Barkhamsted, CT 06063 Phone: 860-212-5961 | |
Ms. Patricia Deer, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 22 Albough Rd, Barkhamsted, CT 06063 Phone: 203-770-5883 |